Source: Medical Product Outsourcing

Implandata Ophthalmic: Implandata Completes Enrollment in ARGOS-SC01 Clinical Study

Twenty-four patients are being evaluated at healthcare institutions in Germany and Switzerland.

Read full article »
Implandata Ophthalmic's Competitors | Implandata Ophthalmic's News | Implandata Ophthalmic's Financials
Stay up-to-date with the latest news on Implandata Ophthalmic
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Max G. Ostermeier's photo - Co-Founder & CEO of Implandata Ophthalmic

Co-Founder & CEO

Max G. Ostermeier

CEO Approval Rating

79/100

Read more
Stay up-to-date with the latest news on Implandata Ophthalmic